| EMA number | EMEA/H/C/004961 |
| ATC code | J05AX |
| Authorisation | 26 September 2019 |
| Withdrawn | 1 January 2023 |
| Revision | 7 |
Trogarzo, in combination with other antiretroviral(s), is indicated for the treatment of adults infected with multidrug resistant HIV-1 infection for whom it is otherwise not possible to construct a suppressive antiviral regimen.